Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maylén Arencibia"'
Autor:
Ana de la Torre, Kirenia Pérez, Aliz M. Vega, Eduardo Santiesteban, Raiza Ruiz, Leonardo Hernández, Dayamí Durrutí, Carmen E. Viada, Liset Sánchez, Mabel Álvarez, Yunier Durán, Yoisbel G. Moreno, Maylén Arencibia, Meylán Cepeda, Milagros Domecq, Leticia Cabrera, Jorge L. Sánchez, José J. Hernández, Ana R. Valls, Luis E. Fernández
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 2016, Iss 10, Pp 5-11 (2016)
Externí odkaz:
https://doaj.org/article/5c7ae05b0fd04052879410a20001971c
Autor:
Alejandro Martínez, Lázaro Manuel Filgueira, Ulises Castillo, Danay Saavedra, Elio Meriño, Mayra Ramos, C. Hidalgo, Alberto Ramírez, Geydi Lorenzo, Julio Betancourt, Carmen Valenzuela, Patricia Lorenzo, Yanelda García, Lilia M Ortega, Henrry Diaz, Meylan Cepeda, Maylén Arencibia, Milagros Domecq, Lizet Sánchez, Tania Crombet, Zaima Mazorra, Daymys Estevez, Alberto Escalona, Rolando E Despaigne, Kalet León, Naivy Sánchez, Leticia Cabrera, Armando Caballero
Publikováno v:
Clinical & Translational Immunology
Objectives COVID‐19 can lead to a hyperinflammatory state. CD6 is a glycoprotein expressed on mature T lymphocytes which is a crucial regulator of the T‐cell activation. Itolizumab is a humanised antibody targeting CD6. Nonclinical and clinical d
Autor:
Liset Sánchez, Ana María Vázquez, Anet Valdes, T. Lahera, A. Linchenat, Leticia Cabrera, Amparo Macías, Sailyn Alfonso, Eduardo Santiesteban, A. Calvo, Tania Crombet, P. Luaces-Lorenzo, Maylén Arencibia, Meylan Cepeda, M. Hernandez
Publikováno v:
Annals of Oncology. 25:iv372
Background: Epithelial ovarian cancer (EOC) is the leading cause of death from gynecologic cancer. Around 75% of the patients are in advanced clinical stages at diagnosis. Despite improvements in cytoreductive surgery and primary chemotherapy over 80